Zika virus structural biology and progress in vaccine development

The growing number of zika virus (ZIKV) infections plus a 20-fold increase in neonatal microcephaly in newborns in Brazil have raised alarms in many countries regarding the threat to pregnant women. Instances of microcephaly and central nervous system malformations continue to increase in ZIKV outbreak regions. ZIKV is a small enveloped positive-strand RNA virus belonging to the Flavivirus genus of the Flaviviridae family. High-resolution ZIKV structures recently identified by cryo-electron microscopy indicate that the overall ZIKV structure is similar to those of other flaviviruses. With its compact surface, ZIKV is more thermally stable than the dengue virus (DENV). ZIKV E proteins have a characteristic “herringbone” structure with a single glycosylation site. The ZIKV E protein, the major protein involved in receptor binding and fusion, is formed as a head-to-tail dimer on the surfaces of viral particles. The E monomer consists of three distinct domains: DI, DII, and DIII. The finger-like DII contains a fusion loop (FL) that is inserted into the host cell endosomal membrane during pH-dependent conformational changes that drive fusion. Quaternary E:E dimer epitopes located at the interaction site of prM and E dimers can be further divided into two dimer epitopes. To date, more than 50 ZIKV vaccine candidates are now in various stages of research and development. Candidate ZIKV vaccines that are currently in phase I/II clinical trials include inactivated whole viruses, recombinant measles viral vector-based vaccines, DNA and mRNA vaccines, and a mosquito salivary peptide vaccine. Stabilized forms of ZIKV E:E dimer proteins have been successfully obtained either by introducing additional inter-subunit disulfide bond(s) in DII or via the direct assembly of E:E dimer proteins by immobilization with monomeric E proteins. The VLP-based approach is another alternative method for presenting native E:E dimer antigens among the vaccine components. Several forms of ZIKV VLPs have been reported featuring the co-expression of the prM-E, prM-E-NS1, C-prM-E, and NS2B/NS3 viral genes in human cells. To minimize the effect of the cross-reactive ADE-facilitating antibodies between ZIKV and DENV, several novel mutations have been reported either in or near the FL of DII or DIII to dampen the production of cross-reactive antibodies. Future ZIKV vaccine design efforts should be focused on eliciting improved neutralizing antibodies with a reduced level of cross-reactivity to confer sterilizing immunity.     

革兰氏阳性菌脂蛋白的研究进展

细菌脂蛋白是细胞膜的重要组成部分,对细菌发挥各种生理活性起重要作用,与营养摄取、环境感知、细胞膜和细胞壁稳态的维持、蛋白质的折叠和定位等过程密切相关。随着生物技术不断发展和完善,越来越多的脂蛋白种类及功能被发现。综述了革兰氏阳性菌中脂蛋白的功能、生物合成过程和应用方面的研究进展,重点介绍了脂蛋白生物合成过程中关键酶磷脂酰甘油转移酶(Lipoprotein diacylglyceryl transferase,Lgt)和脂蛋白信号肽酶(Lipoprotein signal peptidase II,LspA)对革兰氏阳性菌生理活性产生的影响,为今后革兰氏阳性菌脂蛋白的研究提出了展望和建议。     

全球免疫细胞治疗药物开发现状与趋势

目的:从产品开发角度分析免疫细胞治疗类药物的发展现状和未来趋势。方法:检索科睿唯安(Clarivate Analytics)的Cortellis数据库的数据,利用定量分析法和对比分析法对检索结果进行分析。结果:目前已有2种免疫细胞治疗类药物上市,1种免疫细胞治疗类药物处于预注册阶段,4种药物处于临床Ⅲ期,同时大量处于临床Ⅱ/Ⅰ期药物显示未来市场上将有更多免疫细胞治疗类药物。产品交易方面,目前在免疫细胞治疗类药物的商业交易也趋向频繁。通过列举分析目前已发生的交易金额前十的交易,发现其中药物开发及商业化许可是最主要的交易模式。结论:目前免疫细胞治疗类药物市场尚处于起步阶段,但随着未来技术的不断发展改进,相信未来有更多的药物进入商用市场,为癌症及其他疾病的治疗提供新的契机。     

An Attenuated Highly Pathogenic Chinese PRRS Viral Vaccine Confers Cross Protection to Pigs against Challenge with the Emerging PRRSV NADC30-Like Strain

A novel PRRSV strain was isolated in China that was genetically similar to the NADC30 strain which is reported to have spread throughout China. The objective of the present study was to evaluate the cross-protective efficacy of the live vaccine TJM-F92 in young pigs against challenge with a NADC30-like strain, HN201605. Twenty-five PRRSV- and antibody-free pigs were randomly divided into the following five groups: Vac/ChA, Unvac/ChA, Vac/ChB, Unvac/ChB and the mock. The pigs in groups Vac/ChA and Vac/ChB were inoculated intramuscularly with 1 mL TJM-F92 (10^5.0 TCID₅₀/mL). At 28 days post vaccination (0 days post challenge), groups Vac/ChA and Unvac/ChA were inoculated intranasally with 10^4.5 TCID₅₀/mL PRRSV strain TJ F3 (2 mL/pig), while groups Vac/ChB and Unvac/ChB were inoculated, using the same route, with the same dose of the NADC30-like strain HN201605 F3. Protective effects of the PRRSV strain were observed in all pigs in the Vac/ChA and Vac/ChB groups. Neither high fever nor signs of clinical disease were observed through the experiment in these groups, whereas pigs in Unvac/ChA group exhibited serious clinical symptoms, pathological lesions, and weight loss. In Unvac/ChB group, pigs developed milder clinical symptoms, which demonstrated that the NADC30-like strain HN201605 had moderate pathogenicity. The results suggest that the MLV vaccine strain TJM-F92 is an effective and safe vaccine candidate for use in China.     

Failure of neutralizing gp120 monoclonal antibodies to prevent HIV infection of choriocarcinoma-derived trophoblasts

Although placental trophoblasts, the only fetal cells in direct contact with infectious maternal blood, can be infected with HIV, the precise cause for the low transmission rate of virus across the placental barrier is unknown. One of the most common conjectures is that maternal anti-HIV antibodies (Abs) contribute to the protection of the fetus. This hypothesis has been tested in vitro by infecting the CD4-negative placental trophoblast line, BeWo, with HIV-1_IIIB in the presence of serial dilutions of neutralizing monoclonal Abs against the V3 loop (No. 694) or CD4-binding conformational domain (No. 588). The results, based on measurement of p24 production from virus-exposed cells, reveal that the titers of Abs, adequate in preventing the infection of control MT-4 T lymphocytes, were less effective in protecting trophoblasts. Furthermore, PCR analysis of HIV DNA formed after a single round of infection has shown no significant decrease in the number of viral copies in Ab-protected BeWo cells. An anti-HIV serum from a pregnant woman did also have no effect. Although our in vitro observations do not necessarily apply to the in vivo situation, the results suggest that the humoral immune response sustained by neutralizing Abs may be able to protect T lymphocytes, but not placental trophoblasts. The findings are consistent with recent clinical studies demonstrating a lack of correlation between the presence of neutralizing anti-HIV Abs in pregnant women and HIV transmission in utero.     

丙型肝炎病毒核酸疫苗的免疫效果观察

将丙型肝炎病毒Ｃ＋Ｅ１区基因克隆到不同的真核细胞表达载体ｐＣＤＮＡ３．１（＋）和ｐＳＶＬ中,通过肌肉注射和皮下注射免疫ＢＡＬＢ／Ｃ及Ｆ１小鼠后,产生了抗ＨＣＶ／Ｃ区抗体。其中核酸疫苗ｐｃＤＮＡ３．１－ＨＣＶ／Ｃ＋Ｅ１的免疫高峰的出现早于ｐＳＶＬ－ＨＣＶ／Ｃ＋Ｅ１,Ｆ１小鼠的抗体应答强于ＢＡＬＢ／小鼠。肌肉注射优于皮下注射。     

Diversity of plants in cocoa agroforests in the humid forest zone of Southern Cameroon

In the humid forest zone of Southern Cameroon, farmers generally associate cocoa with native and exotic trees in complex agroforestry systems. Despite the socio-economic and ecological importance of these systems, few studies have investigated their plant composition. We investigated tree composition of cocoa agroforests along a gradient of market access, population density and resource use intensity in the humid forest zone of southern Cameroon, comprising (i) the sub-region of Yaoundé, (ii) the sub-region of Mbalmayo, and (iii) the sub-region of Ebolowa. Market access, population density and resource use intensity all decreased from the first to the third sub-region. We quantified the diversity of tree species associated with cocoa within individual agroforests, among agroforests in the same region, and among the three sub-regions, and classified the tree species according to their main uses. A total of 9.1 ha belonging to 60 cocoa agroforests were inventoried in 12 villages. We encountered a total of 206 tree species with an average of 21 tree species per agroforest. In the more urbanized area around Yaoundé, agroforests were less diverse than in the other sub-regions. In all of the agroforests, food producing tree species tended to be more frequent than other species. Two thirds of the food trees were native forest species and one third was introduced. From Ebolowa to Yaoundé, the density of food producing trees doubled and the density of exotic food-producing species increased relative to native species. Some local species producing high-value non-timber forest products were found in the agroforests, but their density was far lower than that of exotic tree species. The agroforests also provide medicine, charcoal and other products for household consumption and sale. We conclude that unless there are specific efforts to promote local forest tree species in cocoa agroforests, these will progressively lose importance with increasing market access, population pressure and land use intensity.     

用转基因植物生产基因工程疫苗

用转基因植物生产外源蛋白质产品是一个有吸引力的廉价生产系统,它有可能替代外源蛋白质的发酵生产系统。通过外源基因的瞬时表达或稳定表达方式,多种疫苗已在植物中产生,在植物中表达的抗原保持了它自身的免疫原性,植物在这方面的应用具有独特的优 点。     

肠毒素性大肠杆菌CS3纤毛抗原在痢疾菌中的表达及其免疫效果研究

首先通过体内外重组的方法,构建了福氏2a痢疾菌T32asd基因缺陷的突变体FaD,作为抗原载体菌;同时,构建包含asd基因的表达质粒pYX102,与FaD一起,构成宿主-载体平衡致死系统,用于在没有抗生素条件选择的情况下,稳定表达克隆在表达质粒上的外源抗原基因.将肠毒素性大肠杆菌的CS3菌毛抗原基因克隆至pYX102,构建成重组表达质粒pYX103,ELISA检测结果证实CS3在痢疾菌中可以很好地表达.免疫小鼠后可诱生相应的抗体,虽然口服免疫和注射免疫产生的CS3抗体效价有一定差别,但对痢疾菌的毒株攻击均可提供较好保护.该结果为细菌性腹泻疫苗的研制提供了候选株.     

人丙型肝炎病毒（HCV）的研究进展

丙型肝炎病毒是在80 年代末才被确认的正链RNA 病毒,目前对丙型肝炎病毒的研究因为没有合适的活体实验模型和细胞系,而受到很大的限制。但由于HCV 的独特性和危害性,而成为众多科学家研究的热点。本文将根据近年来一些HCV 研究的进展,对病毒的结构形态、加工、病毒流行病学,肝癌相关性,病毒分子生物学检测手段以及疫苗研究等方面做一扼要综述